Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triple-Negative Invasive Breast Carcinoma”

67 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 67 results

Early research (Phase 1)Ended earlyNCT04296942
What this trial is testing

BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT)

Who this might be right for
Breast CancerTriple Negative Breast CancerHER2+ Breast Cancer+2 more
National Cancer Institute (NCI) 1
Not applicableLooking for participantsNCT05877859
What this trial is testing

Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab

Who this might be right for
Breast Cancer Triple NegativeBreast Cancer Stage IIBreast Cancer Stage III+1 more
Emory University 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06691594
What this trial is testing

Neoadjuvant Treatment of Triple-Negative Breast Cancer with Stereotactic Radiotherapy, PD-1 Monoclonal Antibody, and Chemotherapy

Who this might be right for
Breast Cancer Invasive
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 20
Large-scale testing (Phase 3)Active Not RecruitingNCT02488967
What this trial is testing

Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

Who this might be right for
Breast AdenocarcinomaEstrogen Receptor NegativeHER2/Neu Negative+7 more
NRG Oncology 782
Testing effectiveness (Phase 2)UnknownNCT02587689
What this trial is testing

Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+1 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 20
Large-scale testing (Phase 3)Study completedNCT03197935
What this trial is testing

Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Hoffmann-La Roche 333
Large-scale testing (Phase 3)Looking for participantsNCT05633654
What this trial is testing

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

Who this might be right for
Triple Negative Breast Cancer
Gilead Sciences 1,514
Testing effectiveness (Phase 2)UnknownNCT02839954
What this trial is testing

CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Large-scale testing (Phase 3)Active Not RecruitingNCT02445391
What this trial is testing

Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

Who this might be right for
Estrogen Receptor NegativeHER2/Neu NegativeInvasive Breast Carcinoma+9 more
ECOG-ACRIN Cancer Research Group 415
Testing effectiveness (Phase 2)Looking for participantsNCT07188246
What this trial is testing

Neoadjuvant, SBRT With Intratumoural Pembrolizumab Followed by Neoadjuvant Chemotherapy in Breast Cancer

Who this might be right for
Breast CancerBreast Cancer Stage IIBreast Cancer Stage III+2 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 40
Testing effectiveness (Phase 2)UnknownNCT00777673
What this trial is testing

Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.

Who this might be right for
Breast Cancer
University of Tennessee Cancer Institute 60
Not applicableWithdrawnNCT01292083
What this trial is testing

Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By Surgery

Who this might be right for
Recurrent Breast CancerStage IA Breast CancerStage IB Breast Cancer+6 more
University of Southern California
Testing effectiveness (Phase 2)Active Not RecruitingNCT03366844
What this trial is testing

Breast Cancer Study of Preoperative Pembrolizumab + Radiation

Who this might be right for
Breast Cancer
Stephen Shiao 66
Testing effectiveness (Phase 2)Study completedNCT01111825
What this trial is testing

Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Puma Biotechnology, Inc. 99
Early research (Phase 1)Ended earlyNCT04139993
What this trial is testing

RBX7455 Before Surgery for the Treatment of Operable Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+20 more
Mayo Clinic 3
Testing effectiveness (Phase 2)Study completedNCT01964924
What this trial is testing

Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Metastatic Triple-Negative Breast Cancer

Who this might be right for
Estrogen Receptor NegativeHER2/Neu NegativeInvasive Breast Carcinoma+4 more
National Cancer Institute (NCI) 37
Not applicableTemporarily pausedNCT04803084
What this trial is testing

Multiparametric MRI as a Non-Invasive Biomarker of the Tumor Microenviroment

Who this might be right for
Breast CancerTriple-negative Breast Cancer
Laura Kennedy 10
Early research (Phase 1)Looking for participantsNCT07137416
What this trial is testing

Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Invasive Breast Carcinoma+13 more
National Cancer Institute (NCI) 36
Not applicableLooking for participantsNCT06744465
What this trial is testing

NearWave Optical Molecular Monitoring

Who this might be right for
Breast CancerHER2-positive Breast CancerTNBC - Triple-Negative Breast Cancer+2 more
Indiana University 15
Not applicableActive Not RecruitingNCT02276443
What this trial is testing

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

Who this might be right for
Invasive Breast CarcinomaStage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7+9 more
M.D. Anderson Cancer Center 798
Load More Results